* Zepp Health Corp ZEPP.N ZEPP.K is expected to report
results on August 21.
* The company's guidance on May 23 2023, for the period
ended June
30, was for revenue between CNY650.00 million and CNY850.00
million.
* Refinitiv's mean analyst estimate for Zepp Health Corp is
for
earnings of 9 fen per share.
* The one available analyst rating on the shares is "strong
buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Zepp Health
Corp
is $3.4, above its last closing price of $1.21.
This summary was machine generated August 18 at 13:34 GMT. All
figures in Chinese yuan renminbi unless otherwise stated